Birth Outcomes in Women Who Have Taken Leflunomide During Pregnancy

OBJECTIVE: In preclinical reproductive studies, leflunomide was found to be embryotoxic and teratogenic. Women treated with leflunomide are advised to avoid pregnancy; those who become pregnant are advised to reduce fetal exposure through a cholestyramine drug elimination procedure. The present stud...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Chambers, Christina D., Johnson, Diana L., Robinson, Luther K., Braddock, Stephen R., Xu, Ronghui, Lopez-Jimenez, Janina, Mirrasoul, Nicole, Salas, Elizabeth, Luo, Yunjun J., Jin, Shelia, Jones, Kenneth Lyons
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2010
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3633589/
https://ncbi.nlm.nih.gov/pubmed/20131283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.27358
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items